Virtual Reality for Preoperative Anxiety in Interventional Cardiology
NCT ID: NCT04242563
Last Updated: 2025-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
156 participants
INTERVENTIONAL
2020-02-02
2021-07-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CONTROL GROUP
No virtual reality
No interventions assigned to this group
INTERVENTION GROUP
Patient equipped with Virtual reality in transfer room.
VIRTUAL REALITY
Patient equipped with virtual reality in transfer room
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VIRTUAL REALITY
Patient equipped with virtual reality in transfer room
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Coronarography procedure programmed for exploration of coronary artery disease following a positive ischemia test, realized in ambulatory
* Patient who has given written consent to participate in the study
Exclusion Criteria
* Hemodynamic instability
* Patient who has already had coronarography
* Prior revascularization by coronary bypass
* End-stage renal disease (Creatinine clearance \<30 ml / min),
* Allergy to iodine contrast agent
* Blind or visually impaired patient (high degree)
* Deaf or hard of hearing patient
* Patient with claustrophobia or unable to wear a mask over the eyes
* Patient whose physical or psychological state could compromise obtaining informed consent and compliance with protocol requirements
* Patient under administrative or judicial supervision
* Foreign patient who does not understand French
* Major patient protected by law (article L1121-8 and L1121-5)
* Pregnant or lactating patient
* Patient not affiliated with social security
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grenoble University Hospital
Grenoble, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Larsson CE, Cabassut V, Peretout P, Marliere S, Vautrin E, Piliero N, Salvat M, Riou L, Vanzetto G, Vilotitch A, Bosson JL, Barone-Rochette G. Assessment of the Objective Effect of Virtual Reality for Preoperative Anxiety in Interventional Cardiology. Am J Cardiol. 2023 Oct 15;205:207-213. doi: 10.1016/j.amjcard.2023.07.130. Epub 2023 Aug 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
38RC19.116
Identifier Type: -
Identifier Source: org_study_id